Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of the Central Nervous System (CNS) and spine. Hydrocephalus Shunts allow excess Cerebrospinal Fluid (CSF) to drain to another area of the body. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hydrocephalus shunts devices market, including market shares of different players within Austria. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the hydrocephalus shunts market in Austria was Integra LifeSciences followed by Medtronic, Aesculap, Sophysa and Spiegelberg.
Hydrocephalus Valves and Hydrocephalus Catheters are covered in this category. Hydrocephalus Valves regulate the flow of CSF out of the brain’s ventricles. Two types of Hydrocephalus Catheters are considered in the market: Antimicrobial Catheters and Standard Catheters.
The value of the hydrocephalus shunts devices market within Austria was expected to be over $1m in 2023.
For the latest complete market share analysis of hydrocephalus shunts device market in Austria, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.